INS and type 1 diabetes mellitus: Twenty-one per cent (123/583) of insulin-treated participants diagnosed with diabetes after 30 years of age met the study criteria for type 1 diabetes and had severe endogenous insulin deficiency (insulin treatment within 3 years and C-peptide <200 pmol/l) (ESM Fig. 1).